4D pharma plc (LBPS)
Market Open
24 Apr, 19:47
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 65
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
3,914 Volume
- Eps
$ 1.65
Previous Close Want to track LBPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4D pharma plc (LBPS) Statistics
Valuation metrics
Market Cap -
Enterprise value -8.17M
Trailing P/E (ttm) -0.56
Forward P/E -
PEG ratio 0.1
Price/Sales (ttm) -
Price/Book (mrq) 0.55
Enterprise Value/Revenue -11.38
Enterprise Value/EBITDA 0.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 1.5
52-Week high 10.38
Beta -
50-Day moving average -
200-Day moving average -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -44.48%
Operating margin -43.7%
Operational effectiveness
Return on assets -0.54%
Return on equity -1.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 5.21%
Book value per share (mrq) 2.41
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
